SCHEMBL9301825

SCHEMBL9301825

CN(C)C1CCN(C(P(=O)(O)O)P(=O)(O)O)C1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.44
L3MBTL3 Q96JM7 1/20 0.34
KDM4D Q6B0I6 1/20 0.34
MCHR1 Q99705 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4371588 0.73 L3MBTL3 (0.34) L3MBTL3KDM4D
SCHEMBL2737220 0.72 HRH3 (0.38) L3MBTL3KDM4D
SCHEMBL12205472 0.72 HRH3 (0.38) L3MBTL3KDM4D
SCHEMBL2737213 0.72 HRH3 (0.38) L3MBTL3KDM4D
SCHEMBL762417 0.71 FDPS (0.56) FDPS
SCHEMBL21016904 0.69 KDM4D (0.34) L3MBTL3KDM4D
SCHEMBL21077335 0.69 KDM4D (0.34) L3MBTL3KDM4D
SCHEMBL13235827 0.69 FDPS (0.53) FDPS
SCHEMBL9301484 0.69 FDPS (0.58) FDPS
SCHEMBL18500463 0.68 KDM4D (0.33) L3MBTL3KDM4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350743-A Treatment of osteoporosis KAKEN PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed
EP-0498424-A1 Bisphosphonic acid derivatives and bone resorption inhibitors containing them Kaken Pharmaceutical Co., Ltd. (JP) 1992-08-12 EP disclosed